M.C.R. Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
M.C.R. Costa has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Oliveira
Kemin Industries, Brasil
1 shared publication - J.C. Borosky
Borosky & Lesch Ltda, Brasil
1 shared publication - Vaclav Vetvicka
Department of Pathology University of Louisville USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 75 (6) , 1065-1068
Euglena gracilis as an adjuvant for the treatment of a dog with chronic kidney disease - case report
A young dog diagnosed with chronic kidney disease, based on clinical changes and sonographic findings (IRIS, 2023), was supplemented with 15mg per kg of body weight per day of inactive dried Euglena gracilis (henceforth called IDEG) as an adjuvant to standard treatments used for the management of chronic kidney disease in dogs. The treatments were divided into two stages, with a total duration of 120 days. At the end of the treatments, the patient showed improvement in vitality, interaction, weight gain, reduction in azotemia, and a 44% decrease in serum C-reactive protein levels.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 75 (6) , 1065-1068
Open AccessEuglena gracilis as an adjuvant for the treatment of a dog with chronic kidney disease - case report
A young dog diagnosed with chronic kidney disease, based on clinical changes and sonographic findings (IRIS, 2023), was supplemented with 15mg per kg of body weight per day of inactive dried Euglena gracilis (henceforth called IDEG) as an adjuvant to standard treatments used for the management of chronic kidney disease in dogs. The treatments were divided into two stages, with a total duration of 120 days. At the end of the treatments, the patient showed improvement in vitality, interaction, weight gain, reduction in azotemia, and a 44% decrease in serum C-reactive protein levels.